Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Improved Outcomes for Liver Transplantation in Patients with Biliary Atresia Since Pediatric End-Stage Liver Disease Implementation: Analysis of the Society of Pediatric Liver Transplantation Registry.

  • Read more about Improved Outcomes for Liver Transplantation in Patients with Biliary Atresia Since Pediatric End-Stage Liver Disease Implementation: Analysis of the Society of Pediatric Liver Transplantation Registry.

QTc Prolongation and Risk of Torsades de Pointes in Hospitalized Pediatric Oncology Patients.

  • Read more about QTc Prolongation and Risk of Torsades de Pointes in Hospitalized Pediatric Oncology Patients.

Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants.

  • Read more about Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants.

50 Years Ago in TheJournalofPediatrics: The Diagnostic Value of Gamma Glutamyl Transpeptidase in Children and Adolescents with Liver Disease.

  • Read more about 50 Years Ago in TheJournalofPediatrics: The Diagnostic Value of Gamma Glutamyl Transpeptidase in Children and Adolescents with Liver Disease.

Improved Referral of Very Low Birthweight Infants to High-Risk Infant Follow-Up in California.

  • Read more about Improved Referral of Very Low Birthweight Infants to High-Risk Infant Follow-Up in California.

Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life.

  • Read more about Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life.

Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial.

  • Read more about Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial.

Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.

  • Read more about Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.

Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.

  • Read more about Respiratory Medications in Infants

50 Years Ago in The Journal of Pediatrics: Radiologic Findings in the Lungs of Premature Infants.

  • Read more about 50 Years Ago in The Journal of Pediatrics: Radiologic Findings in the Lungs of Premature Infants.

Pagination

  • Previous page ‹‹
  • Page 9
  • Next page ››
Subscribe to The Journal of pediatrics

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List